Trademark: 79370637
Word
NUAGE THERAPEUTICS
Status Date
Tuesday, May 14, 2024
Filing Date
Friday, November 25, 2022
Published for Opposition
Tuesday, May 14, 2024
40 Custom manufacture of cell lines for use in the manufacture of biopharmaceutical products; custom manufacture of proteins for third parties; custom manufacture of medicines; custom manufacture of biopharmaceuticals
5 Pharmaceutical preparations for targeting of disordered proteins; chemical, analytical and diagnostic reagents for in vitro medical or veterinary use; chemical reagents for medical use; chemical reagents for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of immune-related, neurological and neurodegenerative diseases
1 Chemicals for use in product development in the fields of science, scientific research and for laboratory use; in vitro analytical and diagnostic reagents for scientific use
42 Scientific, medical, and medical industrial research and development services; medical clinical research studies; laboratory medical research; research and development of new drugs and medical clinical products; analysis of materials; chemical analysis; medical and scientific laboratory services; laboratory medical testing services; medical laboratory services; information and advisory services relating to the aforesaid, including such services provided online from a computer network or via the internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research for scientific or medical purposes; scientific research and development; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals, and gene therapies; medical and scientific research, namely conducting clinical trials; research and development of pharmaceutical products; research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological research, clinical medical research and medical research; product development; biological product development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences
May 25, 2023
Sn Assigned For Sect 66a Appl From Ib
May 30, 2023
Application Filing Receipt Mailed
Sep 6, 2023
Assigned To Examiner
Sep 27, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Sep 27, 2023
Refusal Processed By Mpu
Oct 17, 2023
Refusal Processed By Ib
Mar 27, 2024
Correspondence Received In Law Office
Mar 27, 2024
Teas Response To Office Action Received
May 26, 2023
New Application Office Supplied Data Entered
Sep 8, 2023
Non-Final Action Written
Sep 9, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Mar 28, 2024
Teas/Email Correspondence Entered
Apr 5, 2024
Approved For Pub - Principal Register
Apr 24, 2024
Notification Of Notice Of Publication E-Mailed
May 14, 2024
Published For Opposition
May 14, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
